BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Feb 24, 2014
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Jazz Pharmaceuticals sales and marketing update

Jazz launched Versacloz clozapine in the U.S. to treat severely ill treatment-resistant schizophrenia patients or those at risk of recurrent suicidal behavior with schizophrenia or schizoaffective disorder. Versacloz has a wholesale acquisition cost of $734.14 for...

Read the full 168 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >